Cancer changes more than the body
A breast cancer diagnosis carries a physical treatment plan and an emotional one, though only the first is usually written down. The evidence shows the second matters just as much, and that it follows a different path for each person.
Distress does not follow one path
• A 2026 cohort study following breast cancer patients found that most followed a low, steady level of distress over time, but around 1 in 6 started with high distress that eased within six months, and roughly 1 in 8 experienced distress that stayed moderate or persisted.[1]
• Continuous monitoring and early psychosocial support are recommended, particularly for those in the moderate or high-risk trajectories.
How common is distress?
• A systematic review of women with breast cancer found substantial rates of anxiety, depression and stress, underlining that psychological impact is a common feature of the experience rather than an exception [2]
• The review also noted that most existing evidence comes from high income settings, a gap that limits how well findings generalise across different populations
Fear of recurrence, the fear that lingers
• Research into fear of cancer recurrence found it is closely linked to wider emotional distress, and that the strength of this link can vary depending on a person’s individual circumstances. [3]
• Fear of recurrence is now recognised as one of the most common and persistent psychological challenges survivors face, separate from the distress experienced around diagnosis itself and the end of treatment is recognised as perhaps the most vulnerable time – when others’ expectations are for those finishing treatment to start “going back to their normal life pre-diagnosis.”
Body image and bouncing back
• A study of early breast cancer survivorship found that a person’s perceived ability to bounce back, meaning the sense of having resumed daily life and functioning, is a meaningful marker of psychological adaptation [4]
• The same research described body image after breast cancer as an ongoing interplay between how a person sees their physical changes and what those changes mean to them, rather than a single fixed adjustment
What helps: peer support
• A 2025 analysis found that peer support can meaningfully ease fear of cancer recurrence, helping patients feel less isolated, more able to cope and better able to manage difficult emotions [5]
• Connecting with others who have shared similar experiences was identified as one of the more consistently effective sources of emotional support
What helps: family involvement
• A systematic review of family involvement interventions found they can help manage fear of cancer recurrence for both patients and the caregivers supporting them. [6]
• Involving family alongside the patient, rather than treating emotional support as an individual matter, was associated with better outcomes for both.
What helps: structured psychological support
• A systematic review of psychological distress interventions for breast cancer survivors found a range of approaches showing benefit, while also noting that unclear definitions of distress make it harder to compare and apply findings consistently. [7]
• The review called for interventions that are designed around the specific psychosocial context of breast cancer, rather than adapted from general cancer care.
Getting the right support at the right time
• Macmillan describes a stepped model of psychological support, from information and compassionate communication at the first level, through to specialist psychological therapies at the highest level, with the NICE guidance recommending it for all patients with cancer and their families. [8]
• This model calls for staff at every level, not only specialists, to be able to screen for psychological distress and respond with practical support such as psycho-education and problem solving.
The long-term vision
• We are looking for a future where emotional and psychological support is built into the pathway at every stage, not added on afterwards
• The sector is working towards both physical and psychological personalised treatment pathways and we, at Frontier, are keen to contribute in any way we can to that long-term vision.
Sentinel qCTC™ is an investigational technology platform undergoing development at Frontier Diagnostics Ltd. The platform has not reached design freeze and has not been submitted for regulatory review under IVDR (EU) 2017/746, UK MDR 2002, or FDA 21 CFR Part 809. It is not approved, cleared, or validated for diagnostic, clinical, or commercial research use. All scientific content relating to Sentinel qCTC™ describes developmental aims and does not constitute performance claims.
Sources
[1] Xiong, M. et al. (2026), Psychological Distress Trajectories and Associated Factors in Patients With Breast Cancer: A Cohort Study, Psycho-Oncology
[2] Global prevalence of anxiety, depression and stress in women with breast cancer: A systematic review and meta-analysis (2026), ScienceDirect
[3] Association between fear of cancer recurrence and emotional distress in breast cancer: a latent profile and moderation analysis (2026), Frontiers in Psychiatry
[4] Fear of Cancer Recurrence and Adaptation in Early Breast Cancer Survivorship: A Latent Profile Analysis, PMC
[5] Wang, Y-Z. et al. (2025), Role of peer support on fear of cancer recurrence in patients with breast cancer, Journal of Advanced Nursing
[6] Bu, X. et al. (2025), Family Involvement Interventions on Fear of Cancer Recurrence Management Among Women With Breast Cancer and Their Caregivers: A Systematic Review and Meta-Analysis, Journal of Clinical Nursing
[7] Managing psychological distress in women with breast cancer: A systematic review of intervention trends in the past decade, PMC
[8] Macmillan Cancer Support, What are they? Macmillan funds Psychological and Emotional Support
